Author's Reply—Is It Really Covid-19?,
2020
Northwell Health
Author's Reply—Is It Really Covid-19?, D. Chang, L. M. Epstein
Journal Articles
No abstract provided.
The Covid-19 Pandemic And Acute Aortic Dissections In New York: A Matter Of Public Health.,
2020
Zucker School of Medicine at Hofstra/Northwell
The Covid-19 Pandemic And Acute Aortic Dissections In New York: A Matter Of Public Health., I. El-Hamamsy, D. R. Brinster, J. J. Derose, L. N. Girardi, K. Hisamoto, M. N. Imam, S. Itagaki, P. A. Kurlansky, C. Lau, H. Takayama, +3 Additional Authors
Journal Articles
No abstract provided.
A Comparison Of Existing Risk Prediction Models In Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation,
2020
Zucker School of Medicine at Hofstra/Northwell
A Comparison Of Existing Risk Prediction Models In Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation, B. Worku, M. Gaudino, D. Avgerinos, K. Ramasubbu, I. Gambardella, I. Gulkarov, S. Khin
Journal Articles
© 2020 The Author(s) Background: Patients undergoing consideration for venoarterial extracorporeal membrane oxygenation (VA-ECMO) require an immediate risk profile assessment in the setting of incomplete information. A number of survival prediction models for critically ill patients and patients undergoing elective cardiac surgery or institution of VA-ECMO support have been designed. We assess the ability of these models to predict outcomes in a cohort of patients undergoing institution of VA-ECMO for cardiogenic shock or cardiac arrest. Methods: Fifty-one patients undergoing institution of VA-ECMO support were retrospectively analyzed. APACHE II, SOFA, SAPS II, Encourage, SAVE, and ACEF scores were calculated. Their ability …
Multifocal Extracranial Mycotic Aneurysms In A Patient With Endocarditis,
2020
Zucker School of Medicine at Hofstra/Northwell
Multifocal Extracranial Mycotic Aneurysms In A Patient With Endocarditis, A. M. Spring, M. A. Catalano, B. F. Farber, K. V. Krishnasastry, P. J. Yu
Journal Articles
© 2020 This report describes the case of a 44-year-old man with Streptococcus gallolyticus (formerly S. bovis) endocarditis requiring surgical mitral valve replacement who developed multifocal extracranial mycotic aneurysms after the resolution of infection.
Management Of Elective Aortic Valve Replacement Over The Long Term In The Era Of Covid-19,
2020
Northwell Health
Management Of Elective Aortic Valve Replacement Over The Long Term In The Era Of Covid-19, C. Basman, C. A. Kliger, L. Pirelli, S. J. Scheinerman
Journal Articles
No abstract provided.
European Heart Rhythm Association (Ehra) International Consensus Document On How To Prevent, Diagnose, And Treat Cardiac Implantable Electronic Device Infections - Endorsed By The Heart Rhythm Society (Hrs), The Asia Pacific Heart Rhythm Society (Aphrs), The Latin American Heart Rhythm Society (Lahrs), International Society For Cardiovascular Infectious Diseases (Iscvid) And The European Society Of Clinical Microbiology And Infectious Diseases (Escmid) In Collaboration With The European Association For Cardio-Thoracic Surgery (Eacts), C. Blomström-Lundqvist, V. Traykov, P. A. Erba, H. Burri, J. C. Nielsen, M. G. Bongiorni, J. Poole, G. Boriani, L. M. Epstein, E. Mangoni, +10 Additional Authors
Journal Articles
© 2019 The Author(s). Published by Oxford University Press on behalf of the European Society of Cardiology. Pacemakers, implantable cardiac defibrillators, and cardiac resynchronization therapy devices are potentially life-saving treatments for a number of cardiac conditions, but are not without risk. Most concerning is the risk of a cardiac implantable electronic device (CIED) infection, which is associated with significant morbidity, increased hospitalizations, reduced survival, and increased healthcare costs. Recommended preventive strategies such as administration of intravenous antibiotics before implantation are well recognized. Uncertainties have remained about the role of various preventive, diagnostic, and treatment measures such as skin antiseptics, pocket …
Inpatient Use Of Ambulatory Telemetry Monitors For Covid-19 Patients Treated With Hydroxychloroquine And/Or Azithromycin,
2020
Northwell Health
Inpatient Use Of Ambulatory Telemetry Monitors For Covid-19 Patients Treated With Hydroxychloroquine And/Or Azithromycin, D. Chang, M. Saleh, J. Gabriels, H. Ismail, B. Goldner, J. Willner, S. Beldner, R. Mitra, R. John, L. M. Epstein
Journal Articles
No abstract provided.
Hrs/Ehra/Aphrs/Lahrs/Acc/Aha Worldwide Practice Update For Telehealth And Arrhythmia Monitoring During And After A Pandemic.,
2020
Zucker School of Medicine at Hofstra/Northwell
Hrs/Ehra/Aphrs/Lahrs/Acc/Aha Worldwide Practice Update For Telehealth And Arrhythmia Monitoring During And After A Pandemic., N. Varma, N. F. Marrouche, L. Aguinaga, C. M. Albert, E. Arbelo, J. Choi, M. K. Chung, G. Conte, L. M. Epstein, P. D. Varosy, +13 Additional Authors
Journal Articles
No abstract provided.
An Algorithm For Managing Qt Prolongation In Coronavirus Disease 2019 (Covid-19) Patients Treated With Either Chloroquine Or Hydroxychloroquine In Conjunction With Azithromycin: Possible Benefits Of Intravenous Lidocaine, R. L. Mitra, S. A. Greenstein, L. M. Epstein
Journal Articles
No abstract provided.
Guidance For Rebooting Electrophysiology Through The Covid-19 Pandemic From The Heart Rhythm Society And The American Heart Association Electrocardiography And Arrhythmias Committee Of The Council On Clinical Cardiology: Endorsed By The American College Of Cardiology,
2020
Zucker School of Medicine at Hofstra/Northwell
Guidance For Rebooting Electrophysiology Through The Covid-19 Pandemic From The Heart Rhythm Society And The American Heart Association Electrocardiography And Arrhythmias Committee Of The Council On Clinical Cardiology: Endorsed By The American College Of Cardiology, D. R. Lakkireddy, M. K. Chung, T. F. Deering, R. Gopinathannair, C. M. Albert, L. M. Epstein, C. V. Harding, J. L. Hurwitz, C. C. Jeffery, A. M. Russo, +9 Additional Authors
Journal Articles
© 2020 The Heart Rhythm Society, the American Heart Association, Inc., and the American College of Cardiology Foundation Coronavirus disease 2019 (COVID-19) has presented substantial challenges to patient care and impacted health care delivery, including cardiac electrophysiology practice throughout the globe. Based upon the undetermined course and regional variability of the pandemic, there is uncertainty as to how and when to resume and deliver electrophysiology services for arrhythmia patients. This joint document from representatives of the Heart Rhythm Society, American Heart Association, and American College of Cardiology seeks to provide guidance for clinicians and institutions reestablishing safe electrophysiological care. To …
Hypermetabolism In Critically Ill Patients With Covid-19 And The Effects Of Hypothermia: A Case Series,
2020
Zucker School of Medicine at Hofstra/Northwell
Hypermetabolism In Critically Ill Patients With Covid-19 And The Effects Of Hypothermia: A Case Series, Pj Yu, H Cassiere, K Bocchieri, S Derosa, S Yar, A Hartman
Journal Articles
No abstract provided.
The Paradox Of Stemi Regionalization: Widened Disparities Despite Some Benefits,
2020
Zucker School of Medicine at Hofstra/Northwell
The Paradox Of Stemi Regionalization: Widened Disparities Despite Some Benefits, R. O. Roswell, R. Brown, S. Richardson
Journal Articles
No abstract provided.
Increased Inpatient Mortality For Cardiovascular Patients During The First Covid-19 Epidemic In New York,
2020
Zucker School of Medicine at Hofstra/Northwell
Increased Inpatient Mortality For Cardiovascular Patients During The First Covid-19 Epidemic In New York, S. Richardson, J. S. Hirsch, M. Narasimhan, J M. Crawford, T Mcginn, K W. Davidson, V. Singh
Journal Articles
No abstract provided.
Preoperative Nuclear Stress Testing In The Very Old Patient Population,
2020
Zucker School of Medicine at Hofstra/Northwell
Preoperative Nuclear Stress Testing In The Very Old Patient Population, A. N. Makaryus, J. N. Makaryus, J. A. Diamond
Journal Articles
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. BACKGROUND Elderly patients awaiting moderate to high-risk surgery may undergo nuclear stress testing (NST) in order to evaluate their cardiovascular risk. The prognostic utility of such testing in the very elderly (≥ 85 years) has yet to be fully evaluated. Octogenarians and nonogenarians frequently have a number of concurrent conditions including a high rate of coronary disease, and therefore the prognostic value of NST for their preoperative risk assessment has been questioned. Our evaluation assesses the ability of nuclear stress testing to predict peri-operative cardiac outcomes in …
Diagnostic And Treatment Utility Of Echocardiography In The Management Of The Cardiac Patient,
2020
Zucker School of Medicine at Hofstra/Northwell
Diagnostic And Treatment Utility Of Echocardiography In The Management Of The Cardiac Patient, A. Khalili, J. Drummond, N. Ramjattan, R. Zeltser, A. N. Makaryus
Journal Articles
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. BACKGROUND Echocardiograms are an incredibly useful diagnostic tool due to their lack of harmful radiation, the relative ease and speed with which they can be performed, and their almost ubiquitous availability. Unfortunately, the advantages that support the use of echocardiography can also lead to the overuse of this technology. We sought to evaluate the physician perceived impact echocardiography has on patient management. AIM To evaluate the physician perceived impact echocardiography has on patient management. METHODS Surveys were distributed to the ordering physician for echocardiograms performed at our …
Hrs/Ehra/Aphrs/Lahrs/Acc/Aha Worldwide Practice Update For Telehealth And Arrhythmia Monitoring During And After A Pandemic.,
2020
Zucker School of Medicine at Hofstra/Northwell
Hrs/Ehra/Aphrs/Lahrs/Acc/Aha Worldwide Practice Update For Telehealth And Arrhythmia Monitoring During And After A Pandemic., N. Varma, N. F. Marrouche, L. Aguinaga, C. M. Albert, E. Arbelo, J. Choi, M. K. Chung, G. Conte, L. M. Epstein, H. Rhythm, +14 Additional Authors
Journal Articles
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), started in the city of Wuhan late in 2019. Within a few months, the disease spread toward all parts of the world and was declared a pandemic on March 11, 2020. The current health care dilemma worldwide is how to sustain the capacity for quality services not only for those suffering from COVID-19 but also for non-COVID-19 patients, all while protecting physicians, nurses, and other allied health care workers.
We May Develop Medications Effective Against Covid-19, But Can We Distribute Them Equitably?,
2020
Zucker School of Medicine at Hofstra/Northwell
We May Develop Medications Effective Against Covid-19, But Can We Distribute Them Equitably?, D. J. Kersten, A. N. Makaryus
Journal Articles
No abstract provided.
Institutional Preparedness Strategies For Heart Failure, Durable Left Ventricular Assist Device, And Heart Transplant Patients During The Coronavirus Disease 2019 (Covid-19) Pandemic,
2020
Zucker School of Medicine at Hofstra/Northwell
Institutional Preparedness Strategies For Heart Failure, Durable Left Ventricular Assist Device, And Heart Transplant Patients During The Coronavirus Disease 2019 (Covid-19) Pandemic, A. Bansal, D. Goldstein, S. Schettle, S. Pepitone, B. Lima, D. T. Pham, J. Cowger, A. Schubert, S. P. Pinney
Journal Articles
No abstract provided.
Outcomes In Patients With Severe Covid-19 Disease Treated With Tocilizumab: A Case-Controlled Study,
2020
Zucker School of Medicine at Hofstra/Northwell
Outcomes In Patients With Severe Covid-19 Disease Treated With Tocilizumab: A Case-Controlled Study, G. Rojas-Marte, M. Khalid, O. Mukhtar, A. T. Hashmi, M. A. Waheed, S. Ehrlich, A. Aslam, S. Siddiqui, C. Agarwal, J. Shani, +8 Additional Authors
Journal Articles
© The Author(s) 2020. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For permissions, please email: [email protected]. BACKGROUND: COVID-19 is an ongoing threat to society. Patients who develop the most severe forms of the disease have high mortality. The interleukin-6 inhibitor tocilizumab has the potential to improve outcomes in these patients by preventing the development of cytokine release storm. AIMS: To evaluate the outcomes of patients with severe COVID-19 disease treated with the interleukin-6 inhibitor tocilizumab. METHODS: We conducted a retrospective, case-control, single-center study in patients with severe to critical COVID-19 disease treated …
Response: From Cardiology To Covid The Impact Of A Pandemic On Fellowship Training,
2020
Zucker School of Medicine at Hofstra/Northwell
Response: From Cardiology To Covid The Impact Of A Pandemic On Fellowship Training, J. T. Kuvin
Journal Articles
No abstract provided.
